Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 127

1.

Genomic complexity in pediatric synovial sarcomas (Synobio study): the European pediatric soft tissue sarcoma group (EpSSG) experience.

Orbach D, Mosseri V, Pissaloux D, Pierron G, Brennan B, Ferrari A, Chibon F, Bisogno G, De Salvo GL, Chakiba C, Corradini N, Minard-Colin V, Kelsey A, Ranchère-Vince D.

Cancer Med. 2018 Apr;7(4):1384-1393. doi: 10.1002/cam4.1415. Epub 2018 Mar 13.

2.

Radiogenomics of neuroblastomas: Relationships between imaging phenotypes, tumor genomic profile and survival.

Brisse HJ, Blanc T, Schleiermacher G, Mosseri V, Philippe-Chomette P, Janoueix-Lerosey I, Pierron G, Lapouble E, Peuchmaur M, Fréneaux P, Galmiche L, Algret N, Peycelon M, Michon J, Delattre O, Sarnacki S.

PLoS One. 2017 Sep 25;12(9):e0185190. doi: 10.1371/journal.pone.0185190. eCollection 2017.

3.

[Relapse after rhabdomyosarcoma in childhood and adolescence: Impact of an early detection on survival].

Mallebranche C, Carton M, Minard-Colin V, Desfachelle AS, Rome A, Brisse HJ, Mosseri V, Thébaud E, Pellier I, Boutroux H, Gandemer V, Corradini N, Orbach D.

Bull Cancer. 2017 Jul - Aug;104(7-8):625-635. doi: 10.1016/j.bulcan.2017.05.008. Epub 2017 Jul 4. French.

PMID:
28687117
4.

[Care pathways before diagnosis in children and adolescents with malignancies].

Tatencloux S, Mosseri V, Papillard-Maréchal S, Mesples B, Pellegrino B, Belloy M, Jimènez I, Algret N, Levy D, Michon J, Orbach D.

Bull Cancer. 2017 Feb;104(2):128-138. doi: 10.1016/j.bulcan.2016.11.002. Epub 2016 Dec 7. French.

PMID:
27939009
5.

Ligand-receptor dissociated expression explains high TSLP without prognostic impact in human primary head and neck squamous cell carcinoma.

Guillot-Delost M, Guilleré L, Berger F, Ventre A, Michea P, Sirven P, Pattarini L, Scholer-Dahirel A, Kebir FZ, Huerre M, Chouchane-Mlik O, Lappartient E, Rodriguez J, Jouffroy T, Klijanienko J, Nicolas A, Sastre-Garau X, Honorio S, Mosseri V, Le Peltier N, Sablin MP, Le Tourneau C, Tartour É, Badoual C, Soumelis V.

Oncoimmunology. 2016 Jun 7;5(7):e1179414. doi: 10.1080/2162402X.2016.1179414. eCollection 2016 Jul.

6.

Nonparameningeal head and neck rhabdomyosarcoma in children and adolescents: Lessons from the consecutive International Society of Pediatric Oncology Malignant Mesenchymal Tumor studies.

Orbach D, Mosseri V, Gallego S, Kelsey A, Devalck C, Brenann B, van Noesel MM, Bergeron C, Merks JH, Rechnitzer C, Jenney M, Minard-Colin V, Stevens M.

Head Neck. 2017 Jan;39(1):24-31. doi: 10.1002/hed.24547. Epub 2016 Jul 26.

PMID:
27459057
7.

[Sophrology for patients in oncology].

Barré C, Falcou MC, Mosseri V, Carrié S, Dolbeault S.

Soins. 2015 Nov;(800):17-20. doi: 10.1016/j.soin.2015.09.016. French.

8.

Relapse after localized rhabdomyosarcoma: Evaluation of the efficacy of second-line chemotherapy.

Winter S, Fasola S, Brisse H, Mosseri V, Orbach D.

Pediatr Blood Cancer. 2015 Nov;62(11):1935-41. doi: 10.1002/pbc.25622. Epub 2015 Jul 6.

PMID:
26150380
9.

Outcome of oncoplastic breast-conserving surgery following bracketing wire localization for large breast cancer.

Malhaire C, Hequet D, Falcou MC, Feron JG, Tardivon A, Leduey A, Guillot E, Mosseri V, Rouzier R, Couturaud B, Reyal F.

Breast. 2015 Aug;24(4):370-5. doi: 10.1016/j.breast.2015.02.037. Epub 2015 Apr 23.

PMID:
25913288
10.

Influence of image-defined risk factors on the outcome of patients with localised neuroblastoma. A report from the LNESG1 study of the European International Society of Paediatric Oncology Neuroblastoma Group.

Monclair T, Mosseri V, Cecchetto G, De Bernardi B, Michon J, Holmes K.

Pediatr Blood Cancer. 2015 Sep;62(9):1536-42. doi: 10.1002/pbc.25460. Epub 2015 Feb 8.

PMID:
25663103
11.

Does aggressive local treatment have an impact on survival in children with metastatic rhabdomyosarcoma?

Ben Arush M, Minard-Colin V, Mosseri V, Defachelles AS, Bergeron C, Algret N, Fasola S, André N, Thebaud E, Corradini N, Bernier V, Martelli H, Ranchère D, Orbach D.

Eur J Cancer. 2015 Jan;51(2):193-201. doi: 10.1016/j.ejca.2014.11.009. Epub 2014 Dec 1.

PMID:
25471261
12.

Ewing-like sarcomas with BCOR-CCNB3 fusion transcript: a clinical, radiological and pathological retrospective study from the Société Française des Cancers de L'Enfant.

Cohen-Gogo S, Cellier C, Coindre JM, Mosseri V, Pierron G, Guillemet C, Italiano A, Brugières L, Orbach D, Laurence V, Delattre O, Michon J.

Pediatr Blood Cancer. 2014 Dec;61(12):2191-8. doi: 10.1002/pbc.25210. Epub 2014 Aug 31.

PMID:
25176412
13.

Orbital rhabdomyosarcoma in children: a favorable primary suitable for a less-invasive treatment strategy.

Boutroux H, Cellier C, Mosseri V, Helfre S, Levy C, Desjardins L, Plancher C, Freneaux P, Michon J, Orbach D.

J Pediatr Hematol Oncol. 2014 Nov;36(8):605-12. doi: 10.1097/MPH.0000000000000245.

PMID:
25171453
14.

Clinical characteristics and outcome of patients with neuroblastoma presenting genomic amplification of loci other than MYCN.

Guimier A, Ferrand S, Pierron G, Couturier J, Janoueix-Lerosey I, Combaret V, Mosseri V, Thebaud E, Gambart M, Plantaz D, Marabelle A, Coze C, Rialland X, Fasola S, Lapouble E, Fréneaux P, Peuchmaur M, Michon J, Delattre O, Schleiermacher G.

PLoS One. 2014 Jul 11;9(7):e101990. doi: 10.1371/journal.pone.0101990. eCollection 2014.

15.

Long-term evaluation of orbital rhabdomyosarcoma in children.

Boutroux H, Levy C, Mosseri V, Desjardins L, Plancher C, Helfre S, Freneaux P, Cellier C, Orbach D.

Clin Exp Ophthalmol. 2015 Jan-Feb;43(1):12-9. doi: 10.1111/ceo.12370. Epub 2014 Sep 20.

PMID:
24923774
16.

Extensive pure ductal carcinoma in situ of the breast: identification of predictors of associated infiltrating carcinoma and lymph node metastasis before immediate reconstructive surgery.

Guillot E, Vaysse C, Goetgeluck J, Falcou MC, Couturaud B, Fitoussi A, Fourchotte V, Laki F, Malhaire C, Sigal-Zafrani B, Sastre-Garau X, Bollet MA, Mosseri V, Reyal F.

Breast. 2014 Apr;23(2):97-103. doi: 10.1016/j.breast.2013.12.002. Epub 2013 Dec 31.

PMID:
24388733
17.

Paediatric and adolescent alveolar soft part sarcoma: A joint series from European cooperative groups.

Orbach D, Brennan B, Casanova M, Bergeron C, Mosseri V, Francotte N, Van Noesel M, Rey A, Bisogno G, Pierron G, Ferrari A.

Pediatr Blood Cancer. 2013 Nov;60(11):1826-32. doi: 10.1002/pbc.24683. Epub 2013 Jul 16.

PMID:
23857870
18.

Visualisation of the left anterior descending coronary artery on CT images used for breast radiotherapy planning.

Vennarini S, Fournier-Bidoz N, Aristei C, de Almeida CE, Servois V, Campana F, Mosseri V, Fourquet A, Kirova YM.

Br J Radiol. 2013 May;86(1025):20120643. doi: 10.1259/bjr.20120643. Epub 2013 Feb 25.

19.

Local control and sequelae in localised Ewing tumours of the spine: a French retrospective study.

Vogin G, Helfre S, Glorion C, Mosseri V, Mascard E, Oberlin O, Gaspar N.

Eur J Cancer. 2013 Apr;49(6):1314-23. doi: 10.1016/j.ejca.2012.12.005. Epub 2013 Feb 8.

PMID:
23402991
20.

Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project.

Schleiermacher G, Mosseri V, London WB, Maris JM, Brodeur GM, Attiyeh E, Haber M, Khan J, Nakagawara A, Speleman F, Noguera R, Tonini GP, Fischer M, Ambros I, Monclair T, Matthay KK, Ambros P, Cohn SL, Pearson AD.

Br J Cancer. 2012 Oct 9;107(8):1418-22. doi: 10.1038/bjc.2012.375. Epub 2012 Sep 13.

21.

Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial.

Lannering B, Rutkowski S, Doz F, Pizer B, Gustafsson G, Navajas A, Massimino M, Reddingius R, Benesch M, Carrie C, Taylor R, Gandola L, Björk-Eriksson T, Giralt J, Oldenburger F, Pietsch T, Figarella-Branger D, Robson K, Forni M, Clifford SC, Warmuth-Metz M, von Hoff K, Faldum A, Mosseri V, Kortmann R.

J Clin Oncol. 2012 Sep 10;30(26):3187-93. doi: 10.1200/JCO.2011.39.8719. Epub 2012 Jul 30.

PMID:
22851561
22.

Prognosis of malignant sacrococcygeal germ cell tumours according to their natural history and surgical management.

De Corti F, Sarnacki S, Patte C, Mosseri V, Baranzelli MC, Martelli H, Conter C, Frappaz D, Orbach D.

Surg Oncol. 2012 Jun;21(2):e31-7. doi: 10.1016/j.suronc.2012.03.001. Epub 2012 Mar 28.

PMID:
22459912
23.

Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study).

Schleiermacher G, Michon J, Ribeiro A, Pierron G, Mosseri V, Rubie H, Munzer C, Bénard J, Auger N, Combaret V, Janoueix-Lerosey I, Pearson A, Tweddle DA, Bown N, Gerrard M, Wheeler K, Noguera R, Villamon E, Cañete A, Castel V, Marques B, de Lacerda A, Tonini GP, Mazzocco K, Defferrari R, de Bernardi B, di Cataldo A, van Roy N, Brichard B, Ladenstein R, Ambros I, Ambros P, Beiske K, Delattre O, Couturier J.

Br J Cancer. 2011 Dec 6;105(12):1940-8. doi: 10.1038/bjc.2011.472. Epub 2011 Nov 10.

24.

[Brain metastases in breast cancer. Epidemiology and natural history. The Institut Curie experience].

Gachet J, Giroux J, Girre V, Brain É, Kirova Y, Mignot L, Mazeron JJ, Dutertre G, Pouit B, Mosseri V, Falcou MC, Cottu PH.

Bull Cancer. 2011 Apr;98(4):357-69. doi: 10.1684/bdc.2011.1339. French.

25.

Frequent hSNF5/INI1 germline mutations in patients with rhabdoid tumor.

Bourdeaut F, Lequin D, Brugières L, Reynaud S, Dufour C, Doz F, André N, Stephan JL, Pérel Y, Oberlin O, Orbach D, Bergeron C, Rialland X, Fréneaux P, Ranchere D, Figarella-Branger D, Audry G, Puget S, Evans DG, Pinas JC, Capra V, Mosseri V, Coupier I, Gauthier-Villars M, Pierron G, Delattre O.

Clin Cancer Res. 2011 Jan 1;17(1):31-8. doi: 10.1158/1078-0432.CCR-10-1795.

26.

Excellent outcome with reduced treatment in infants with nonmetastatic and unresectable neuroblastoma without MYCN amplification: results of the prospective INES 99.1.

Rubie H, De Bernardi B, Gerrard M, Canete A, Ladenstein R, Couturier J, Ambros P, Munzer C, Pearson AD, Garaventa A, Brock P, Castel V, Valteau-Couanet D, Holmes K, Di Cataldo A, Brichard B, Mosseri V, Marquez C, Plantaz D, Boni L, Michon J.

J Clin Oncol. 2011 Feb 1;29(4):449-55. doi: 10.1200/JCO.2010.29.5196. Epub 2010 Dec 20.

PMID:
21172879
27.

Changes over three decades in outcome and the prognostic influence of age-at-diagnosis in young patients with neuroblastoma: a report from the International Neuroblastoma Risk Group Project.

Moroz V, Machin D, Faldum A, Hero B, Iehara T, Mosseri V, Ladenstein R, De Bernardi B, Rubie H, Berthold F, Matthay KK, Monclair T, Ambros PF, Pearson AD, Cohn SL, London WB.

Eur J Cancer. 2011 Mar;47(4):561-71. doi: 10.1016/j.ejca.2010.10.022. Epub 2010 Nov 26.

PMID:
21112770
28.

Accumulation of segmental alterations determines progression in neuroblastoma.

Schleiermacher G, Janoueix-Lerosey I, Ribeiro A, Klijanienko J, Couturier J, Pierron G, Mosseri V, Valent A, Auger N, Plantaz D, Rubie H, Valteau-Couanet D, Bourdeaut F, Combaret V, Bergeron C, Michon J, Delattre O.

J Clin Oncol. 2010 Jul 1;28(19):3122-30. doi: 10.1200/JCO.2009.26.7955. Epub 2010 Jun 1.

PMID:
20516441
29.

Study of the length of hospital stay for free flap reconstruction of oral and pharyngeal cancer in the context of the new French casemix-based funding.

Girod A, Brancati A, Mosseri V, Kriegel I, Jouffroy T, Rodriguez J.

Oral Oncol. 2010 Mar;46(3):190-4. doi: 10.1016/j.oraloncology.2009.12.002. Epub 2010 Jan 8.

PMID:
20060773
30.

Postirradiation sarcoma: clinicopathologic features and role of chemotherapy in the treatment strategy.

des Guetz G, Chapelier A, Mosseri V, Dorval T, Asselain B, Pouillart P.

Sarcoma. 2009;2009:764379. doi: 10.1155/2009/764379.

31.

Use of chimeric subscapular artery system free flaps for soft-tissue reconstruction of the oral cavity and oropharynx: advantages and donor-site morbidity.

Girod A, Nadaud F, Mosseri V, Jouffroy T, Rodriguez J.

Plast Reconstr Surg. 2009 Dec;124(6):445e-6e. doi: 10.1097/PRS.0b013e3181bcf7ba. No abstract available.

PMID:
19952611
32.

Women and squamous cell carcinomas of the oral cavity and oropharynx: is there something new?

Girod A, Mosseri V, Jouffroy T, Point D, Rodriguez J.

J Oral Maxillofac Surg. 2009 Sep;67(9):1914-20. doi: 10.1016/j.joms.2009.04.031.

PMID:
19686929
33.

From childhood to adulthood: long-term outcome of medulloblastoma patients. The Institut Curie experience (1980-2000).

Frange P, Alapetite C, Gaboriaud G, Bours D, Zucker JM, Zerah M, Brisse H, Chevignard M, Mosseri V, Bouffet E, Doz F.

J Neurooncol. 2009 Nov;95(2):271-279. doi: 10.1007/s11060-009-9927-z. Epub 2009 Jun 12.

PMID:
19521664
34.

Overall genomic pattern is a predictor of outcome in neuroblastoma.

Janoueix-Lerosey I, Schleiermacher G, Michels E, Mosseri V, Ribeiro A, Lequin D, Vermeulen J, Couturier J, Peuchmaur M, Valent A, Plantaz D, Rubie H, Valteau-Couanet D, Thomas C, Combaret V, Rousseau R, Eggert A, Michon J, Speleman F, Delattre O.

J Clin Oncol. 2009 Mar 1;27(7):1026-33. doi: 10.1200/JCO.2008.16.0630. Epub 2009 Jan 26.

PMID:
19171713
35.

The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report.

Cohn SL, Pearson AD, London WB, Monclair T, Ambros PF, Brodeur GM, Faldum A, Hero B, Iehara T, Machin D, Mosseri V, Simon T, Garaventa A, Castel V, Matthay KK; INRG Task Force.

J Clin Oncol. 2009 Jan 10;27(2):289-97. doi: 10.1200/JCO.2008.16.6785. Epub 2008 Dec 1.

36.

Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group.

De Bernardi B, Mosseri V, Rubie H, Castel V, Foot A, Ladenstein R, Laureys G, Beck-Popovic M, de Lacerda AF, Pearson AD, De Kraker J, Ambros PF, de Rycke Y, Conte M, Bruzzi P, Michon J; SIOP Europe Neuroblastoma Group.

Br J Cancer. 2008 Oct 7;99(7):1027-33. doi: 10.1038/sj.bjc.6604640. Epub 2008 Sep 2.

37.

Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients?

Girre V, Falcou MC, Gisselbrecht M, Gridel G, Mosseri V, Bouleuc C, Poinsot R, Vedrine L, Ollivier L, Garabige V, Pierga JY, Diéras V, Mignot L.

J Gerontol A Biol Sci Med Sci. 2008 Jul;63(7):724-30.

PMID:
18693227
38.

Preoperative Wilms tumor rupture: a retrospective study of 57 patients.

Brisse HJ, Schleiermacher G, Sarnacki S, Helfre S, Philippe-Chomette P, Boccon-Gibod L, Peuchmaur M, Mosseri V, Aigrain Y, Neuenschwander S.

Cancer. 2008 Jul 1;113(1):202-13. doi: 10.1002/cncr.23535.

39.

BAC array CGH distinguishes mutually exclusive alterations that define clinicogenetic subtypes of gliomas.

Idbaih A, Marie Y, Lucchesi C, Pierron G, Manié E, Raynal V, Mosseri V, Hoang-Xuan K, Kujas M, Brito I, Mokhtari K, Sanson M, Barillot E, Aurias A, Delattre JY, Delattre O.

Int J Cancer. 2008 Apr 15;122(8):1778-86.

40.

Radiation and chemotherapy combination for nasopharyngeal carcinoma in children: Radiotherapy dose adaptation after chemotherapy response to minimize late effects.

Orbach D, Brisse H, Helfre S, Klijanienko J, Bours D, Mosseri V, Rodriguez J.

Pediatr Blood Cancer. 2008 Apr;50(4):849-53.

PMID:
17973328
41.

Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplification.

Schleiermacher G, Michon J, Huon I, d'Enghien CD, Klijanienko J, Brisse H, Ribeiro A, Mosseri V, Rubie H, Munzer C, Thomas C, Valteau-Couanet D, Auvrignon A, Plantaz D, Delattre O, Couturier J; Société Française des Cancers de l'Enfant (SFCE).

Br J Cancer. 2007 Jul 16;97(2):238-46. Epub 2007 Jun 19.

42.

Phase II study of temozolomide in relapsed or refractory high-risk neuroblastoma: a joint Société Française des Cancers de l'Enfant and United Kingdom Children Cancer Study Group-New Agents Group Study.

Rubie H, Chisholm J, Defachelles AS, Morland B, Munzer C, Valteau-Couanet D, Mosseri V, Bergeron C, Weston C, Coze C, Auvrignon A, Djafari L, Hobson R, Baunin C, Dickinson F, Brisse H, McHugh K, Biassoni L, Giammarile F, Vassal G; Société Françaisedes Cancers de l'Enfant; United Kingdom Children Cancer Study Group-New Agents Group Study.

J Clin Oncol. 2006 Nov 20;24(33):5259-64.

PMID:
17114659
43.

Treatment of high risk medulloblastomas in children above the age of 3 years: a SFOP study.

Verlooy J, Mosseri V, Bracard S, Tubiana AL, Kalifa C, Pichon F, Frappaz D, Chastagner P, Pagnier A, Bertozzi AI, Gentet JC, Sariban E, Rialland X, Edan C, Bours D, Zerah M, Le Gales C, Alapetite C, Doz F.

Eur J Cancer. 2006 Nov;42(17):3004-14. Epub 2006 Sep 7.

PMID:
16956759
44.

Role of chemotherapy resistance genes in outcome of neuroblastoma.

de Cremoux P, Jourdan-Da-Silva N, Couturier J, Tran-Perennou C, Schleiermacher G, Fehlbaum P, Doz F, Mosseri V, Delattre O, Klijanienko J, Vielh P, Michon J.

Pediatr Blood Cancer. 2007 Mar;48(3):311-7.

PMID:
16609945
45.

Prognostic value of International Neuroblastoma Pathology Classification in localized resectable peripheral neuroblastic tumors: a histopathologic study of localized neuroblastoma European Study Group 94.01 Trial and Protocol.

Navarro S, Amann G, Beiske K, Cullinane CJ, d'Amore ES, Gambini C, Mosseri V, De Bernardi B, Michon J, Peuchmaur M; European Study Group 94.01 Trial and Protocol.

J Clin Oncol. 2006 Feb 1;24(4):695-9.

PMID:
16446343
46.

Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers.

Badoual C, Hans S, Rodriguez J, Peyrard S, Klein C, Agueznay Nel H, Mosseri V, Laccourreye O, Bruneval P, Fridman WH, Brasnu DF, Tartour E.

Clin Cancer Res. 2006 Jan 15;12(2):465-72.

47.

Surgical risk factors in primary surgery for localized neuroblastoma: the LNESG1 study of the European International Society of Pediatric Oncology Neuroblastoma Group.

Cecchetto G, Mosseri V, De Bernardi B, Helardot P, Monclair T, Costa E, Horcher E, Neuenschwander S, Tomà P, Rizzo A, Michon J, Holmes K.

J Clin Oncol. 2005 Nov 20;23(33):8483-9.

PMID:
16293878
48.

Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French Society of Pediatric Oncology Study.

Oyharcabal-Bourden V, Kalifa C, Gentet JC, Frappaz D, Edan C, Chastagner P, Sariban E, Pagnier A, Babin A, Pichon F, Neuenschwander S, Vinchon M, Bours D, Mosseri V, Le Gales C, Ruchoux M, Carrie C, Doz F.

J Clin Oncol. 2005 Jul 20;23(21):4726-34.

PMID:
16034048
49.

Outcome of second malignancies after retinoblastoma: a retrospective analysis of 25 patients treated at the Institut Curie.

Aerts I, Pacquement H, Doz F, Mosseri V, Desjardins L, Sastre X, Michon J, Rodriguez J, Schlienger P, Zucker JM, Quintana E.

Eur J Cancer. 2004 Jul;40(10):1522-9.

PMID:
15196536
50.

Anal canal cancer treatment: practical limitations of routine prescription of concurrent chemotherapy and radiotherapy.

Chauveinc L, Buthaud X, Falcou MC, Mosseri V, De la Rochefordière A, Pierga JY, Girodet J, Salmon RJ.

Br J Cancer. 2003 Dec 1;89(11):2057-61.

Supplemental Content

Loading ...
Support Center